ProCE Banner Activity

What are the Current Recommendations for Metastatic Hormone-Sensitive Prostate Cancer in 2019?

Slideset Download
In this downloadable slideset, Daniel W. Lin, MD, reviews the latest evidence and guidelines supporting the optimal management of patients with metastatic hormone-sensitive prostate cancer.

Released: May 03, 2019

Expiration: May 01, 2020

No longer available for credit.

Share

Faculty

Daniel W. Lin

Daniel W. Lin, MD

Professor and Chief of Urologic Oncology
Department of Urology
University of Washington
Seattle, Washington

Provided by

Provided by National Comprehensive Cancer Network.
ProCE Banner

Supporters

Supported by independent educational grants from

Astellas Text

Pfizer, Inc.

Faculty Disclosure

Primary Author

Daniel W. Lin, MD

Professor and Chief of Urologic Oncology
Department of Urology
University of Washington
Seattle, Washington